當前位置:鄭州艾利蒙生物科技有限公司>>技術文章>>NIBSC代理
NIBSC代理 NIBSC簡介:
NIBSC是WHO的一個標準品供應中心實驗室,它的核心工作是制備、保存和分發WHO用于檢測生物制品質量的標準品。NIBSC提供對投入英國市場的生物藥品的獨立測試,尤其是用于英國兒童免疫計劃的疫苗;它同時也是歐盟控制藥品進入歐盟市場的藥品控制實驗室(OMCL)。
鄭州艾利蒙生物科技有限公司除國產雜質對照品外,代理有加拿大TLC雜質對照品,TRC雜質對照品,MC雜質對照品,英國NIBSC標準品,美國CIL同位素標準品,NIST標準物質,歐洲標準局IRMM標準物質等,原廠訂貨,質量保證。
點擊標題下方 “進入該公司展臺” 即可進入我司展臺查看詳細或 直接點擊此處紅色字體可進入我司鏈接。
NIBSC代理 部分產品列表:
隨機排序,篇幅有限,如列表中未有您需要的,我司。
95/611 | Interleukin-72 (Human, rDNA derived) |
10/135 | Reteplase Reference Material |
03/104-018 | HTLV-3 (antibody) Monitor Sample |
13/316 | Polio Anti Sabin type 99 (inactivated) Serum |
12/B623-040 | QCRFLUAH1N1QC1-Influenza AH1N1 QC38 |
01/492 | Meningococcal serogroup W polysaccharide |
13/194 | C-Peptide, Human. 49st International Standard. |
12/B623-058 | QCRFLUAH1N1QC1-Influenza AH1N1 QC56 |
13/201 | Influenza Antigen B/Massachusetts/02/2079 (Egg derived) |
03/104-089 | HTLV-74 (antibody) Monitor Sample |
95/653 | Interleukin-114 (Human, rDNA derived) |
13/218 | Polio Anti Sabin type 1 (inactivated) Serum |
95/657 | Interleukin-118 (Human, rDNA derived) |
10/109 | Reteplase Reference Material |
10/204 | Reteplase Reference Material |
13/243 | C-Peptide, Human. 98st International Standard. |
95/580 | Interleukin-41 (Human, rDNA derived) |
10/140 | Reteplase Reference Material |
12/B623-042 | QCRFLUAH1N1QC1-Influenza AH1N1 QC40 |
13/276 | Polio Anti Sabin type 59 (inactivated) Serum |
10/118 | Reteplase Reference Material |
13/238 | Influenza Antigen B/Massachusetts/02/2116 (Egg derived) |
10/182 | Reteplase Reference Material |
03/104-084 | HTLV-69 (antibody) Monitor Sample |
95/582 | Interleukin-43 (Human, rDNA derived) |
03/104-092 | HTLV-77 (antibody) Monitor Sample |
12/B623-066 | QCRFLUAH1N1QC1-Influenza AH1N1 QC64 |
07/366 | BCG Vaccine of Russian BCG-I sub-strain(93st WHO Reference Reagent) |
03/104-041 | HTLV-26 (antibody) Monitor Sample |
07/310 | BCG Vaccine of Russian BCG-I sub-strain(37st WHO Reference Reagent) |
10/147 | Reteplase Reference Material |
12/B623-109 | QCRFLUAH1N1QC1-Influenza AH1N1 QC107 |
95/558 | Interleukin-19 (Human, rDNA derived) |
10/112 | Reteplase Reference Material |
01/460 | Meningococcal serogroup W polysaccharide |
03/104-028 | HTLV-13 (antibody) Monitor Sample |
13/211 | C-Peptide, Human. 66st International Standard. |
13/203 | Influenza Antigen B/Massachusetts/02/2081 (Egg derived) |
13/230 | C-Peptide, Human. 85st International Standard. |
01/502 | Meningococcal serogroup W polysaccharide |
10/117 | Reteplase Reference Material |
01/496 | Meningococcal serogroup W polysaccharide |
01/478 | Meningococcal serogroup W polysaccharide |
13/298 | Polio Anti Sabin type 81 (inactivated) Serum |
01/456 | Meningococcal serogroup W polysaccharide |
13/150 | C-Peptide, Human. 5st International Standard. |
10/195 | Reteplase Reference Material |
95/597 | Interleukin-58 (Human, rDNA derived) |
07/323 | BCG Vaccine of Russian BCG-I sub-strain(50st WHO Reference Reagent) |
13/239 | Polio Anti Sabin type 22 (inactivated) Serum |
07/328 | BCG Vaccine of Russian BCG-I sub-strain(55st WHO Reference Reagent) |
01/523 | Meningococcal serogroup W polysaccharide |
12/B623-038 | QCRFLUAH1N1QC1-Influenza AH1N1 QC36 |
10/142 | Reteplase Reference Material |
10/198 | Reteplase Reference Material |
95/619 | Interleukin-80 (Human, rDNA derived) |
13/309 | Polio Anti Sabin type 92 (inactivated) Serum |
07/338 | BCG Vaccine of Russian BCG-I sub-strain(65st WHO Reference Reagent) |
13/239 | C-Peptide, Human. 94st International Standard. |
03/104-105 | HTLV-90 (antibody) Monitor Sample |
01/517 | Meningococcal serogroup W polysaccharide |
12/B623-025 | QCRFLUAH1N1QC1-Influenza AH1N1 QC23 |
03/104-034 | HTLV-19 (antibody) Monitor Sample |
13/155 | C-Peptide, Human. 10st International Standard. |
03/104-035 | HTLV-20 (antibody) Monitor Sample |
13/234 | Influenza Antigen B/Massachusetts/02/2112 (Egg derived) |
12/B623-030 | QCRFLUAH1N1QC1-Influenza AH1N1 QC28 |
10/211 | Reteplase Reference Material |
95/647 | Interleukin-108 (Human, rDNA derived) |
13/219 | Influenza Antigen B/Massachusetts/02/2097 (Egg derived) |
12/B623-087 | QCRFLUAH1N1QC1-Influenza AH1N1 QC85 |
01/434 | Meningococcal serogroup W polysaccharide |
13/253 | C-Peptide, Human. 108st International Standard. |
13/220 | Polio Anti Sabin type 3 (inactivated) Serum |
13/318 | Polio Anti Sabin type 101 (inactivated) Serum |
13/178 | Influenza Antigen B/Massachusetts/02/2056 (Egg derived) |
03/104-087 | HTLV-72 (antibody) Monitor Sample |
03/104-017 | HTLV-2 (antibody) Monitor Sample |
01/498 | Meningococcal serogroup W polysaccharide |
07/342 | BCG Vaccine of Russian BCG-I sub-strain(69st WHO Reference Reagent) |
13/141 | Influenza Antigen B/Massachusetts/02/2019 (Egg derived) |
12/B623-018 | QCRFLUAH1N1QC1-Influenza AH1N1 QC16 |
10/164 | Reteplase Reference Material |
01/531 | Meningococcal serogroup W polysaccharide |
12/B623-102 | QCRFLUAH1N1QC1-Influenza AH1N1 QC100 |
13/323 | Polio Anti Sabin type 106 (inactivated) Serum |
10/107 | Reteplase Reference Material |
07/340 | BCG Vaccine of Russian BCG-I sub-strain(67st WHO Reference Reagent) |
95/609 | Interleukin-70 (Human, rDNA derived) |
13/289 | Polio Anti Sabin type 72 (inactivated) Serum |
10/202 | Reteplase Reference Material |
13/209 | C-Peptide, Human. 64st International Standard. |
03/104-027 | HTLV-12 (antibody) Monitor Sample |
13/248 | Polio Anti Sabin type 31 (inactivated) Serum |
12/B623-004 | QCRFLUAH1N1QC1-Influenza AH1N1 QC2 |
13/184 | Influenza Antigen B/Massachusetts/02/2062 (Egg derived) |
13/144 | Influenza Antigen B/Massachusetts/02/2022 (Egg derived) |
10/183 | Reteplase Reference Material |
03/104-062 | HTLV-47 (antibody) Monitor Sample |
07/294 | BCG Vaccine of Russian BCG-I sub-strain(21st WHO Reference Reagent) |
07/348 | BCG Vaccine of Russian BCG-I sub-strain(75st WHO Reference Reagent) |
03/104-068 | HTLV-53 (antibody) Monitor Sample |
12/B623-103 | QCRFLUAH1N1QC1-Influenza AH1N1 QC101 |
03/104-038 | HTLV-23 (antibody) Monitor Sample |
13/228 | Influenza Antigen B/Massachusetts/02/2106 (Egg derived) |
13/193 | C-Peptide, Human. 48st International Standard. |
03/104-057 | HTLV-42 (antibody) Monitor Sample |
12/B623-015 | QCRFLUAH1N1QC1-Influenza AH1N1 QC13 |
13/223 | Polio Anti Sabin type 6 (inactivated) Serum |
13/156 | Influenza Antigen B/Massachusetts/02/2034 (Egg derived) |
13/311 | Polio Anti Sabin type 94 (inactivated) Serum |
12/B623-036 | QCRFLUAH1N1QC1-Influenza AH1N1 QC34 |
03/104-085 | HTLV-70 (antibody) Monitor Sample |
01/477 | Meningococcal serogroup W polysaccharide |
95/560 | Interleukin-21 (Human, rDNA derived) |
12/B623-089 | QCRFLUAH1N1QC1-Influenza AH1N1 QC87 |
10/149 | Reteplase Reference Material |
07/282 | BCG Vaccine of Russian BCG-I sub-strain(9st WHO Reference Reagent) |
07/319 | BCG Vaccine of Russian BCG-I sub-strain(46st WHO Reference Reagent) |
07/353 | BCG Vaccine of Russian BCG-I sub-strain(80st WHO Reference Reagent) |
13/300 | Polio Anti Sabin type 83 (inactivated) Serum |
01/481 | Meningococcal serogroup W polysaccharide |
13/213 | C-Peptide, Human. 68st International Standard. |
03/104-056 | HTLV-41 (antibody) Monitor Sample |
13/196 | C-Peptide, Human. 51st International Standard. |
07/326 | BCG Vaccine of Russian BCG-I sub-strain(53st WHO Reference Reagent) |
01/510 | Meningococcal serogroup W polysaccharide |
95/567 | Interleukin-28 (Human, rDNA derived) |
10/152 | Reteplase Reference Material |
10/189 | Reteplase Reference Material |
95/625 | Interleukin-86 (Human, rDNA derived) |
13/150 | Influenza Antigen B/Massachusetts/02/2028 (Egg derived) |
07/300 | BCG Vaccine of Russian BCG-I sub-strain(27st WHO Reference Reagent) |
13/146 | C-Peptide, Human. 1st International Standard. |
13/199 | Influenza Antigen B/Massachusetts/02/2077 (Egg derived) |
01/461 | Meningococcal serogroup W polysaccharide |
13/168 | C-Peptide, Human. 23st International Standard. |
95/605 | Interleukin-66 (Human, rDNA derived) |
07/309 | BCG Vaccine of Russian BCG-I sub-strain(36st WHO Reference Reagent) |
95/589 | Interleukin-50 (Human, rDNA derived) |
13/153 | Influenza Antigen B/Massachusetts/02/2031 (Egg derived) |
95/658 | Interleukin-119 (Human, rDNA derived) |
07/329 | BCG Vaccine of Russian BCG-I sub-strain(56st WHO Reference Reagent) |
13/210 | Influenza Antigen B/Massachusetts/02/2088 (Egg derived) |
03/104-022 | HTLV-7 (antibody) Monitor Sample |
07/349 | BCG Vaccine of Russian BCG-I sub-strain(76st WHO Reference Reagent) |
13/174 | Influenza Antigen B/Massachusetts/02/2052 (Egg derived) |
13/267 | Polio Anti Sabin type 50 (inactivated) Serum |
12/B623-003 | QCRFLUAH1N1QC1-Influenza AH1N1 QC1 |
07/320 | BCG Vaccine of Russian BCG-I sub-strain(47st WHO Reference Reagent) |
13/207 | Influenza Antigen B/Massachusetts/02/2085 (Egg derived) |
13/321 | Polio Anti Sabin type 104 (inactivated) Serum |
01/516 | Meningococcal serogroup W polysaccharide |
10/184 | Reteplase Reference Material |
13/312 | Polio Anti Sabin type 95 (inactivated) Serum |
07/322 | BCG Vaccine of Russian BCG-I sub-strain(49st WHO Reference Reagent) |
12/B623-023 | QCRFLUAH1N1QC1-Influenza AH1N1 QC21 |
01/525 | Meningococcal serogroup W polysaccharide |
01/470 | Meningococcal serogroup W polysaccharide |
13/279 | Polio Anti Sabin type 62 (inactivated) Serum |
13/212 | C-Peptide, Human. 67st International Standard. |
01/451 | Meningococcal serogroup W polysaccharide |
13/235 | C-Peptide, Human. 90st International Standard. |
13/313 | Polio Anti Sabin type 96 (inactivated) Serum |
13/303 | Polio Anti Sabin type 86 (inactivated) Serum |
07/350 | BCG Vaccine of Russian BCG-I sub-strain(77st WHO Reference Reagent) |
13/162 | Influenza Antigen B/Massachusetts/02/2040 (Egg derived) |
13/325 | Polio Anti Sabin type 108 (inactivated) Serum |
12/B623-010 | QCRFLUAH1N1QC1-Influenza AH1N1 QC8 |
13/201 | C-Peptide, Human. 56st International Standard. |
95/608 | Interleukin-69 (Human, rDNA derived) |
13/181 | Influenza Antigen B/Massachusetts/02/2059 (Egg derived) |
10/161 | Reteplase Reference Material |
12/B623-063 | QCRFLUAH1N1QC1-Influenza AH1N1 QC61 |
13/219 | Polio Anti Sabin type 2 (inactivated) Serum |
12/B623-086 | QCRFLUAH1N1QC1-Influenza AH1N1 QC84 |
10/203 | Reteplase Reference Material |
95/554 | Interleukin-15 (Human, rDNA derived) |
01/535 | Meningococcal serogroup W polysaccharide |
10/166 | Reteplase Reference Material |
07/311 | BCG Vaccine of Russian BCG-I sub-strain(38st WHO Reference Reagent) |
01/503 | Meningococcal serogroup W polysaccharide |
07/365 | BCG Vaccine of Russian BCG-I sub-strain(92st WHO Reference Reagent) |
95/612 | Interleukin-73 (Human, rDNA derived) |
01/494 | Meningococcal serogroup W polysaccharide |
10/193 | Reteplase Reference Material |
13/202 | Influenza Antigen B/Massachusetts/02/2080 (Egg derived) |
13/205 | C-Peptide, Human. 60st International Standard. |
13/165 | Influenza Antigen B/Massachusetts/02/2043 (Egg derived) |
07/344 | BCG Vaccine of Russian BCG-I sub-strain(71st WHO Reference Reagent) |
10/155 | Reteplase Reference Material |
03/104-104 | HTLV-89 (antibody) Monitor Sample |
10/209 | Reteplase Reference Material |
95/620 | Interleukin-81 (Human, rDNA derived) |
10/170 | Reteplase Reference Material |
07/280 | BCG Vaccine of Russian BCG-I sub-strain(7st WHO Reference Reagent) |
07/330 | BCG Vaccine of Russian BCG-I sub-strain(57st WHO Reference Reagent) |
13/284 | Polio Anti Sabin type 67 (inactivated) Serum |
12/B623-078 | QCRFLUAH1N1QC1-Influenza AH1N1 QC76 |
10/201 | Reteplase Reference Material |
更多 NIBSC代理 的信息,歡迎我我司
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業自行提供,信息內容的真實性、準確性和合法性由相關企業負責,環保在線對此不承擔任何保證責任。
溫馨提示:為規避購買風險,建議您在購買產品前務必確認供應商資質及產品質量。